A new paper has explored the extended difficulties experienced by some people following psychedelic drug use and discusses psychedelic harm reduction.
At PSYCH Symposium in the British Museum on 6 July a conversation between Professor Robin Carhart-Harris and journalist Kate Spicer explored the impact of psychedelic research...
PSYCH Symposium returned at the British Museum on 6 July to explore how psychedelic medicines can innovate healthcare – from mental health to eating disorders and...
A new analysis led by NYU Grossman School of Medicine and the National Drug Early Warning System (NDEWS) at the University of Florida found a 349%...
New research suggests that ketamine nasal spray may prove a safe and effective treatment for refractory chronic migraine.
PSYCH Symposium: London 2023 is returning on 6 July at the iconic British Museum to explore the latest challenges and opportunities in the field of psychedelic...
Psychedelics work by altering neural networks in our brains – this first-of-its-kind partnership between Clerkenwell Health and MYndspan will help understand this link definitively, and provide...
In 1943, Swiss chemist Albert Hofmann took the first LSD trip.
Study participants demonstrated a durable response at least six months, and in some cases a year or more, after their final MDMA-assisted therapy session during the...
The University of California, Davis has launched the Institute for Psychedelics and Neurotherapeutics to advance basic knowledge about the mechanisms of psychedelics.
